| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |